MedTrace Logo

Gadoxetic Acid-enhanced MR Evaluation of Hepatocellular Carcinoma and Dysplastic Nodules in the Cirrhotic Liver

NCT01501240 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2014-01-28

No results posted yet for this study

Summary

A prospective intra-individual study to investigate the diagnostic performance of gadoxetic acid-enhanced MR for the patients with liver cirrhosis using thin-section whole-explant as standard of reference

Conditions

Sponsors & Collaborators

  • Bayer

    collaborator INDUSTRY

  • Jae Ho Byun

    lead OTHER

Principal Investigators

  • Jae Ho Byun, MD, PhD · University of Ulsan College of Medicine, Asan Medical Center

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2012-12-31
Completion
2013-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01501240 on ClinicalTrials.gov